These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 34207236)

  • 1. Hyperalphalipoproteinemia and Beyond: The Role of HDL in Cardiovascular Diseases.
    Giammanco A; Noto D; Barbagallo CM; Nardi E; Caldarella R; Ciaccio M; Averna MR; Cefalù AB
    Life (Basel); 2021 Jun; 11(6):. PubMed ID: 34207236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia.
    Yamashita S; Maruyama T; Hirano K; Sakai N; Nakajima N; Matsuzawa Y
    Atherosclerosis; 2000 Oct; 152(2):271-85. PubMed ID: 10998455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperalphalipoproteinemia: characterization of a cardioprotective profile associating increased high-density lipoprotein2 levels and decreased hepatic lipase activity.
    Sich D; Saïdi Y; Giral P; Lagrost L; Egloff M; Auer C; Gautier V; Turpin G; Beucler I
    Metabolism; 1998 Aug; 47(8):965-73. PubMed ID: 9711993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two novel mutations and functional analyses of the CETP and LIPC genes underlying severe hyperalphalipoproteinemia.
    Plengpanich W; Siriwong S; Khovidhunkit W
    Metabolism; 2009 Aug; 58(8):1178-84. PubMed ID: 19428034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum apolipoprotein E-rich HDL-C levels in the subjects with hyperalphalipoproteinemia].
    Inano K; Miida T; Okada M
    Rinsho Byori; 1997 Sep; 45(9):903-7. PubMed ID: 9311266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia.
    Maruyama T; Sakai N; Ishigami M; Hirano K; Arai T; Okada S; Okuda E; Ohya A; Nakajima N; Kadowaki K; Fushimi E; Yamashita S; Matsuzawa Y
    Atherosclerosis; 2003 Jan; 166(1):177-85. PubMed ID: 12482565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of plasma lipid transfer proteins in reverse cholesterol transport.
    Yamashita S; Sakai N; Hirano K; Ishigami M; Maruyama T; Nakajima N; Matsuzawa Y
    Front Biosci; 2001 Mar; 6():D366-87. PubMed ID: 11229884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.
    Hirano K; Yamashita S; Nakajima N; Arai T; Maruyama T; Yoshida Y; Ishigami M; Sakai N; Kameda-Takemura K; Matsuzawa Y
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1053-9. PubMed ID: 9194754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein.
    Yamashita S; Hirano K; Sakai N; Matsuzawa Y
    Biochim Biophys Acta; 2000 Dec; 1529(1-3):257-75. PubMed ID: 11111094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resequencing CETP, LIPC and LIPG genes in Thai subjects with hyperalphalipoproteinemia.
    Khovidhunkit W; Chartyingcharoen P; Siriwong S; Limumpornpetch P; Plengpanich W
    Am J Cardiol; 2012 Jul; 110(1):62-6. PubMed ID: 22464213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerotic cardiovascular disease in hyperalphalipoproteinemia due to LIPG variants.
    Cole J; Blackhurst DM; Solomon GAE; Ratanjee BD; Benjamin R; Marais AD
    J Clin Lipidol; 2021; 15(1):142-150.e2. PubMed ID: 33414088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase.
    Hirano K; Yamashita S; Kuga Y; Sakai N; Nozaki S; Kihara S; Arai T; Yanagi K; Takami S; Menju M
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1849-56. PubMed ID: 7583564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderate hyperalphalipoproteinaemia in a Brazilian population is related to lipoprotein lipase activity, apolipoprotein A-I concentration, age and body mass index.
    Alarcon SB; Oliveira HC; Harada LM; Nunes VS; Kaplan D; Quintão EC; de Faria EC
    Clin Sci (Lond); 2004 Jan; 106(1):11-7. PubMed ID: 12889988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes.
    Maïga SF; Kalopissis AD; Chabert M
    Biochimie; 2014 Jan; 96():56-66. PubMed ID: 24012775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Overexpression of Endothelial Lipase Lowers High-Density Lipoprotein but Maintains Reverse Cholesterol Transport in Mice: Role of Scavenger Receptor Class B Type I/ATP-Binding Cassette Transporter A1-Dependent Pathways.
    Takiguchi S; Ayaori M; Yakushiji E; Nishida T; Nakaya K; Sasaki M; Iizuka M; Uto-Kondo H; Terao Y; Yogo M; Komatsu T; Ogura M; Ikewaki K
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1454-1467. PubMed ID: 29748333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader assay.
    Nagano M; Yamashita S; Hirano K; Ito M; Maruyama T; Ishihara M; Sagehashi Y; Oka T; Kujiraoka T; Hattori H; Nakajima N; Egashira T; Kondo M; Sakai N; Matsuzawa Y
    J Lipid Res; 2002 Jul; 43(7):1011-8. PubMed ID: 12091484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I.
    Collet X; Tall AR; Serajuddin H; Guendouzi K; Royer L; Oliveira H; Barbaras R; Jiang XC; Francone OL
    J Lipid Res; 1999 Jul; 40(7):1185-93. PubMed ID: 10393203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-evaluation of cholesteryl ester transfer protein function in atherosclerosis based upon genetics and pharmacological manipulation.
    Yamashita S; Matsuzawa Y
    Curr Opin Lipidol; 2016 Oct; 27(5):459-72. PubMed ID: 27454452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved plasma cholesterol efflux capacity from human macrophages in patients with hyperalphalipoproteinemia.
    El Khoury P; Plengpanich W; Frisdal E; Le Goff W; Khovidhunkit W; Guerin M
    Atherosclerosis; 2014 May; 234(1):193-9. PubMed ID: 24674903
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.